On this page
Does DC Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
DC Medicaid's Wegovy and Zepbound forms say anti-obesity drugs are excluded from coverage, so it does not cover them for weight loss in its fee-for-service pharmacy program. Read from state documents Nov 6, 2026.
What DC Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. DC Department of Health Care Finance.
WegovyNo
Prior authorization form covers heart risk reduction only, in adults with cardiovascular disease and a BMI of 27 or higher.
“Please note: anti-obesity drugs are excluded from coverage for the District DHCF Pharmacy Program.”
DC Department of Health Care Finance (Prime Therapeutics, DC PBM) · No effective date on the document · read Nov 6, 2026
ZepboundNo
Prior authorization form covers moderate to severe obstructive sleep apnea in adults with a BMI of 27 or higher.
“Note: Anti-obesity drugs are excluded from coverage for the District DHCF Pharmacy Program.”
DC Department of Health Care Finance (Prime Therapeutics, DC PBM) · No effective date on the document · read Nov 6, 2026
OzempicNo
GLP-1 prior authorization form requires a type 2 diabetes diagnosis, a trial of metformin or insulin, and an HbA1c value.
“Does the member have a diagnosis of Type 2 Diabetes (not pre-diabetes)?”
DC Department of Health Care Finance (Prime Therapeutics, DC PBM) · No effective date on the document · read Nov 6, 2026
“Please note GLP-1 drugs FDA labeled for weight loss are excluded from coverage for the District DHCF Pharmacy Program.”
DC Department of Health Care Finance (Prime Therapeutics, DC PBM) · No effective date on the document · read Nov 6, 2026
MounjaroNo
GLP-1 prior authorization form requires a type 2 diabetes diagnosis, a trial of metformin or insulin, and an HbA1c value.
“Does the member have a diagnosis of Type 2 Diabetes (not pre-diabetes)?”
DC Department of Health Care Finance (Prime Therapeutics, DC PBM) · No effective date on the document · read Nov 6, 2026
“Please note GLP-1 drugs FDA labeled for weight loss are excluded from coverage for the District DHCF Pharmacy Program.”
DC Department of Health Care Finance (Prime Therapeutics, DC PBM) · No effective date on the document · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from DC Department of Health Care Finance documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
538 prescriptions
Ozempic and Mounjaro, 2025
21,667 prescriptions
Neighbours covering weight loss
1 of 2
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your DC Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed DC Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether DC Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does DC Medicaid pay for?
27,754 GLP-1 prescriptions in 2025, 44th of the 50 states and DC, with $22.0 million reimbursed before rebates. Counting the share other payers covered, $28.1 million.
Prescriptions, 2025
27,754
44th of 51
Medicaid paid
$22.0M
43rd of 51, before rebates
Per prescription
$794
$1,051 nationally
Weight-loss brands
1.9%
34th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Washington, DC is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 1.9% of DC Medicaid's GLP-1 prescriptions in 2025 (538). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was DC Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 15,986 | 58% | $13.0 million | $814 |
| Mounjaro | 5,681 | 20% | $4.8 million | $837 |
| Trulicity | 5,232 | 19% | $3.8 million | $725 |
| Zepboundapproved for weight management | 358 | 1.3% | $240,849 | $673 |
| Rybelsus | 303 | 1.1% | $116,802 | $385 |
| Wegovyapproved for weight management | 180 | 0.6% | $130,694 | $726 |
| Bydureon | 14 | 0.1% | $119 | $8 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in Washington, DC?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Washington, DC and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 2 states next to Washington, DC covers GLP-1s for weight loss through Medicaid: Virginia.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Washington, DC | Not covered | 0 | none verified |
| Maryland | Not covered | 19 | $39/moWellmedr |
| Virginia | Covered | 19 | $39/moWellmedr |



